Investor List:

Top Diagnostics Seed Investors in New York City (6)

Know someone who's actively diligencing and investing? Add them to this list.
About this list
We’ve compiled a list of the top Diagnostics investors. The goal is to help Founders find the best investors to target and get introduced to.
Photo of Will Weisman, Managing Director at KittyHawk Ventures
Will Weisman
KittyHawk Ventures·Managing Director
Sweet spot: $2.0M
Range: $250K - $15.0M
Investors in New York (NY), Investors in Warsaw (Poland), Investors in Vancouver (BC), Investors in San Francisco (CA), Investors in Hayward (CA), Investors in Dallas (TX), Investors in San Diego (CA), Investors in Detroit (MI), Investors in Boston (MA)
Investors in AI, Investors in BioTech, Investors in DeepTech, Investors in Diagnostics, Investors in IoT, Investors in Los Angeles / Southern California (Other Lists), Investors in Medical Devices, Investors in Robotics, Investors in Space, Investors in TransportationTech, Investors in Web3/Blockchain, Investors in Investors who invested in diverse founders (Other Lists), Investors in Investors who invested in female founders (Other Lists), Investors in Investors who were founders (Other Lists)
Photo of George C. Petrocheilos, Managing Partner at Catalio Capital
George C. Petrocheilos
Catalio Capital·Managing Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Baltimore (MD), Investors in Athens (Greece), Investors in New York (NY)
Investors in BioTech, Investors in Cybersecurity, Investors in Diagnostics, Investors in Drug Delivery, Investors in Medical Devices, Investors in New York City (Other Lists), Investors in Robotics
Photo of Jennifer Hartt, Managing Director at Ben Franklin Technology Partners of Southeastern Pennsylvania
Jennifer Hartt
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Philadelphia (PA)
Investors in BioTech, Investors in Diagnostics, Investors in Digital Health, Investors in Health & Hospital Services, Investors in Health IT, Investors in Medical Devices, Investors in New York City (Other Lists)
Photo of Iain Dukes, Venture Partner at OrbiMed
Iain Dukes
OrbiMed·Venture Partner
Sweet spot: $4.0M
Range: $1M - $75.0M
Investors in New York (NY)
Investors in BioTech, Investors in BioTech, Investors in Diagnostics, Investors in Diagnostics, Investors in Digital Health, Investors in Digital Health, Investors in Health & Hospital Services, Investors in Health & Hospital Services, Investors in Health IT, Investors in Health IT, Investors in Medical Devices, Investors in Medical Devices, Investors in New York City (Other Lists), Investors in Pharmaceuticals, Investors in Pharmaceuticals
Photo of Peter Thompson, Partner at OrbiMed
Peter Thompson
OrbiMed·Partner
Sweet spot: $4.0M
Range: $1M - $75.0M
Investors in New York (NY), Investors in San Francisco (CA)
Investors in BioTech, Investors in BioTech, Investors in Diagnostics, Investors in Diagnostics, Investors in Digital Health, Investors in Digital Health, Investors in Health & Hospital Services, Investors in Health & Hospital Services, Investors in Health IT, Investors in Health IT, Investors in Pharmaceuticals, Investors in Pharmaceuticals, Investors in Seattle / Portland (Other Lists)
Photo of Charles Steinman, Analyst at OrbiMed
Charles Steinman
OrbiMed·Analyst
Sweet spot: $4.0M
Range: $1M - $75.0M
Investors in New York (NY)
Investors in BioTech, Investors in BioTech, Investors in Diagnostics, Investors in Diagnostics, Investors in Medical Devices, Investors in Medical Devices, Investors in New York City (Other Lists)
Get new data & insights delivered to your inbox